Evaluation of variation of mineral density and bone microarchitecture after allogeneic HSCTs transplant in hematologic malignancies. Comparison with the general population.
Cytological diagnosis of acute myeloid leukemia (AML) with indication for a first-line allo-HSCTs transplant
Patient affiliated to the social security system
For women of childbearing age, use of reliable contraception throughout the study in accordance with the CPR of the drugs used.
The patient must be able to comply with study visits and per protocol procedures
Person under guardianship or curatorship, or unable to understand the purpose of the study.
Hematologic malignancies other than AML
History of neoplasia with bone involvement (sarcoma, multiple myeloma, metastasis...) and/or any solid cancer less than 5 years old
History of fracture of the femoral neck prior to the diagnosis of hematologic malignancies
Single group
Bone osteodensitometry
Other interventionEvaluation of bone osteodensitometry
bone mineral density evaluation
bone mineral density evaluation post-transplant
bone mineral density evaluation
long term bone mineral density evaluation
Bone architectural abnormalities and fracture risk
evaluation of bone architectural abnormalities and fracture risk
bone remodeling markers
Dosage of bone remodeling markers
Pain evaluation
Pain evaluation (EVA)
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
